Navigation Links
Docs Say No to Pulling Drugs Containing Acetaminophen off the Market

FLEMINGTON, N.J., July 20 /PRNewswire/ -- A new national media study among 589 physicians revealed that the majority of physicians (82%) do not believe that drugs containing acetaminophen should be pulled off the market.

(Logo: )

The study was conducted by HCD Research using its website during July 17-19, to obtain physicians' perceptions of a CNN news clip which outlined an FDA committee's recent concern regarding acetaminophen, a drug found in several common prescription and non-prescription products. To view agreement curves and detailed results go to:

"Physicians expressed sharp disagreement when the CNN reporter stated: 'the committee said yank them off the market -- no more Vicodin, no more Percocet,' as evidenced by the downward spiral of our automated response curves," explained Glenn Kessler, president and CEO, HCD Research.

The majority of doctors (70%) reported that the FDA's warnings and concerns regarding the acetaminophen have not affected their prescribing habits.

Among the findings:

"Have your prescribing habits changed since becoming aware of the FDA's recent warnings and concerns regarding the drug Acetaminophen? Select all that apply."

    More likely to prescribe products containing
     Acetaminophen                                          1%

    Less likely to prescribe products containing
     Acetaminophen                                          8%

    More likely to discuss warnings and dosage
     instructions with patients who are prescribed
     or use Acetaminophen products                         29%

    No change in prescribing habits for products
     containing Acetaminophen                              70%

    Other                                                   1%

"Do you think the FDA should pull Acetaminophen products?"

    Yes, both prescription and non-prescription
     Acetaminophen products                                 4%

    Yes, prescription Acetaminophen products only           6%

    Yes, non-prescription Acetaminophen products
     only                                                   3%

    Yes, they should pull only certain products
     containing Acetaminophen.                              6%

    No, they should not pull any Acetaminophen
     products                                              82%

While viewing the video, participants indicated their levels of agreement by moving their mouse from left to right on a continuum. The responses were recorded in quarter-second intervals and reported in the form of curves. The participants were also asked to respond to post-viewing questions.

HCD Research is a marketing and communications research company headquartered in Flemington, NJ. For additional information on HCD Research, access the company's website at ( is a media measurement website that provides the media and general public with a venue to view Americans' perceptions of popular and controversial media events and advertisements.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
2. High-Salt Diet Dampens Effects of Blood Pressure Drugs
3. Debate Over Advertising Prescription Drugs to Consumers Goes Online at New Website
4. Crime, Drugs and Health Problems Face Vancouvers Downtown Eastside
5. CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers
6. China Nepstar Chain Drugstore Acquires Drugstores in Beijing
7. The National Council on Aging and CVS/pharmacy Educate Tampa Seniors on Medication Management and How to Save Money on Prescription Drugs
8. Dry mouth linked to prescription and over the counter drugs
9. CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers
10. Post-transplant combo can replace toxic immune-suppressing drugs in monkeys
11. New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: